Can Stem Cells Help Chronic Obstructive Pulmonary Disorder?

What is Chronic Obstructive Pulmonary Disorder?

Chronic Obstructive Pulmonary Disorder (COPD) is a debilitating lung disease, meaning that it worsens over time without proper treatment and symptom management. There are four stages of progression for the disease, starting with mild and ending with very severe. The restriction of airflow into and out of the lungs characterizes the disease. Chronic obstructive pulmonary disorder is the umbrella term for sufferers who have been diagnosed with or show signs of emphysema and/or chronic bronchitisStem cell treatments for chronic obstructive pulmonary disorder are emerging as a viable option for people suffering from this condition.

Treatments for Chronic Obstructive Pulmonary Disorder 

There isn’t a known cure for chronic obstructive pulmonary disorder, but that does not mean that the disease can’t be managed. Many physicians prescribe bronchodilators to help open the airways to allow for more airflow. Also, it is typical that a chronic obstructive pulmonary disorder treatment plan to include a series of breathing and aerobic exercise to improve some pulmonary functioning. For people in the most severe, late stages of chronic obstructive pulmonary disorder, supplemental oxygen is also used for treatment. Although most of these treatments are supportive, they do not assist in the reversal of any symptoms, they are used to deter the progression of the disease. A group of groundbreaking doctors have discovered over the past few years that the use of stem cells can have a beneficial effect in treating chronic obstructive pulmonary disorder and other lung diseases.

What are Stem Cells? 

Stem cells are essential for any living organism. They have the capability for self-renewal and duplication, able to form any type of tissue or organ in your body. Adult stem cells from one organ are capable of creating tissue for another organ, which is called plasticity. It has been established that adult stem cells are able to be transferred into any one single organ in your body.

Stem Cell Treatments for Chronic Obstructive Pulmonary Disorder 

In the case of lung diseases, autologous stem cells are used, meaning they come from the patient’s own body, and can be found in the patient’s venous blood. Stem cells originating from bone marrow or blood have the ability to form many types of various cells.

During the procedure, stem cell therapy involves isolating adult stem cells from bone marrow, which needs special laboratory methods to gather them. After being extracted from the patient’s body, they are isolated. They are then given back to the patient intravenously or through a method using a nebulizer. It surprises many people to hear that the therapy is minimally invasive and normally an outpatient procedure.

These procedures should be completed in a clinical venue under the supervision of a trained physician. It takes a doctor that has sought specific training in stem cell therapy to perform the treatment safely and proficiently.

If you would like to learn more about our available stem cell treatments for chronic obstructive pulmonary disorder, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.